Home-based vs. Supervised Exercise for People With Claudication

Status Completed

Clinical Trial Summary

The purpose of this study is to examine the effects of a home-based exercise rehabilitation program compared to a supervised exercise program on intermittent claudication (leg pain or discomfort) and ambulatory function.

Clinical Trial Description

This study seeks to 1) compare the changes in ambulatory function, vascular function, and health-related quality of life in patients limited by intermittent claudication following a home-based exercise rehabilitation program, a supervised exercise program, and a light resistance training exercise program; and 2) determine whether changes in walking efficiency, calf muscle circulation, and calf muscle oxygen are the reasons by which both home-based and supervised exercise rehabilitation improve ambulatory function.

We hypothesize that a home-based exercise program utilizing new physical activity monitoring technology that can accurately quantify exercise adherence as well as the intensity, duration, and volume of exercise sessions will result in similar changes in ambulatory function, vascular function, and health-related quality of life compared to a standard, supervised exercise program. Further, both the home-based and supervised exercise rehabilitation programs will result in greater changes in ambulatory function, vascular function, and health-related quality of life than a light resistance training exercise program. Finally, we hypothesize that the changes in walking efficiency, calf muscle circulation, and calf muscle oxygen will each be predictive of improved ambulation following the home-based exercise program as well as the supervised exercise program.

The 3-month program will consist of walking 3 times per week, with progressive increases in duration and intensity. The two walking exercise programs will be matched on the estimated caloric expenditure during the training sessions. Patients in the control group will perform light resistance training without any walking exercise. ;

Study Design

Related Conditions & MeSH terms

Intermittent Claudication

Clinical Trial Details

NCT number	NCT00618670
Study type	Interventional
Source	University of Oklahoma
Contact
Status	Completed
Phase	N/A
Start date	September 2006
Completion date	September 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05400395` - Clinical Trial for GNX80 in Intermittent Claudication	Phase 4
Active, not recruiting	`NCT02341716` - Hospital- and Home-based Supervised Exercise Versus UNsupervised Walk Advice For Patients With InTermittent Claudication	N/A
Completed	`NCT02041169` - Lower Extremity Peripheral Arterial Disease and Exercise Ischemia	N/A
Completed	`NCT00822172` - Evaluation of Cilostazol in Combination With L-Carnitine	Phase 4
Recruiting	`NCT00538408` - Whole Body Magnetic Resonance Angiography in Ischemic Patients	N/A
Completed	`NCT00388128` - Caffeine and Intermittent Claudication	Phase 3
Recruiting	`NCT00146666` - Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)	Phase 2
Completed	`NCT00134277` - Trial Comparing Different Medical Devices for Infragenual Dilatation	N/A
Completed	`NCT01256775` - Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)	Phase 2
Completed	`NCT00029991` - Extract of Ginkgo Biloba (EGB 761) and Vascular Function	Phase 1/Phase 2
Recruiting	`NCT06299956` - Supervised Exercise-based Rehabilitation for People With Intermittent Claudication in Denmark	N/A
Not yet recruiting	`NCT05335161` - A New Heat Therapy Device for Home-based Leg Heating in Patients With Lower-extremity Peripheral Artery Disease	Phase 1
Completed	`NCT04390282` - Secondary Prevention and Application-based Lifestyle Support for Patients With Intermittent Claudication	N/A
Completed	`NCT03271710` - Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System	N/A
Completed	`NCT02380794` - Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule	Phase 2
Active, not recruiting	`NCT02276937` - Randomized Phase IIb Trial of DVC1-0101	Phase 2
Completed	`NCT02097082` - Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System	N/A
Recruiting	`NCT00539266` - Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia	Phase 2/Phase 3
Completed	`NCT00071266` - The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC	Phase 3
Completed	`NCT00300690` - Choice of Material for Above-Knee Femoro-Popliteal Bypass Prosthetic Graft (PopUp)	Phase 4